Business Description

Description
CB Scientific Inc through its U.S. and international subsidiaries provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 4.18
Equity-to-Asset -1.92
Debt-to-Equity -0.08
Debt-to-EBITDA -0.03
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -72.56
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 87.34
9-Day RSI 68.74
14-Day RSI 57.6
6-1 Month Momentum % -60.26
12-1 Month Momentum % -60.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.27
Quick Ratio 0.24
Cash Ratio 0.24
Days Inventory 4197.5
Days Sales Outstanding 10.29
Days Payable 14819

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -9.65

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 98.46
Operating Margin % -1602.31
Net Margin % -1585.39
FCF Margin % -663.08
ROA % -848.85
ROIC % -571.94
ROC (Joel Greenblatt) % -8800

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 62
EV-to-EBIT -4.07
EV-to-EBITDA -4.07
EV-to-Revenue 66.14
EV-to-FCF -9.97
Earnings Yield (Greenblatt) % -24.57
FCF Yield % -9.82